GSK and Amgen Add Select Meds to TrumpRx, Offering New Angles on the Pharm-to-Table Future
And new insights on past, present, and future Medicare price “negotiations”
Mar 16, 2026
Subscribe to Cost Curve Apex to read the rest.
Upgrade to Apex to get access to this post and other subscriber-only content.
Upgrade